JAZZ vs MDB · P/E 1988, rev $4.07B vs rev $2.46B
Jazz Pharmaceuticals PLC (JAZZ) versus MongoDB (MDB) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
MongoDB (MDB) is a software - infrastructure company listed on US.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported MDB revenue for 2026-01-31 was $2.46B. Net income was -$71.2M. Revenue was up 22.8% from 2025-01-31 to 2026-01-31. MDB currently screens at market cap $17.16B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. MDB currently screens at market cap $17.16B.
Not investment advice. Open the JAZZ and MDB stock pages for the full models.
Not investment advice.